GB9722682D0 - Pharmaceutical products - Google Patents

Pharmaceutical products

Info

Publication number
GB9722682D0
GB9722682D0 GBGB9722682.3A GB9722682A GB9722682D0 GB 9722682 D0 GB9722682 D0 GB 9722682D0 GB 9722682 A GB9722682 A GB 9722682A GB 9722682 D0 GB9722682 D0 GB 9722682D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical products
adjuvant
mucosal tissue
vaccine composition
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9722682.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Catalent UK Swindon Encaps Ltd
Original Assignee
Catalent UK Swindon Encaps Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catalent UK Swindon Encaps Ltd filed Critical Catalent UK Swindon Encaps Ltd
Priority to GBGB9722682.3A priority Critical patent/GB9722682D0/en
Publication of GB9722682D0 publication Critical patent/GB9722682D0/en
Priority to AU96359/98A priority patent/AU9635998A/en
Priority to DE69826019T priority patent/DE69826019T2/de
Priority to EP98950200A priority patent/EP1024824B1/en
Priority to AT98950200T priority patent/ATE274919T1/de
Priority to DK98950200T priority patent/DK1024824T3/da
Priority to ES98950200T priority patent/ES2227885T3/es
Priority to JP2000517737A priority patent/JP2001521007A/ja
Priority to PT98950200T priority patent/PT1024824E/pt
Priority to PCT/GB1998/003209 priority patent/WO1999021579A1/en
Priority to US10/136,000 priority patent/US20020197321A1/en
Priority to US10/835,680 priority patent/US20040265377A1/en
Priority to US11/778,788 priority patent/US20080014260A1/en
Priority to US12/714,832 priority patent/US20100330183A1/en
Priority to US13/181,128 priority patent/US20120034305A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Formation And Processing Of Food Products (AREA)
GBGB9722682.3A 1997-10-27 1997-10-27 Pharmaceutical products Ceased GB9722682D0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GBGB9722682.3A GB9722682D0 (en) 1997-10-27 1997-10-27 Pharmaceutical products
PCT/GB1998/003209 WO1999021579A1 (en) 1997-10-27 1998-10-27 Solid dispersing vaccine composition for oral delivery
ES98950200T ES2227885T3 (es) 1997-10-27 1998-10-27 Composicion de vacuna de dispersion solida para administracion oral.
PT98950200T PT1024824E (pt) 1997-10-27 1998-10-27 Composicao de vacina dispersivel solida para administracao oral
EP98950200A EP1024824B1 (en) 1997-10-27 1998-10-27 Solid dispersing vaccine composition for oral delivery
AT98950200T ATE274919T1 (de) 1997-10-27 1998-10-27 Feste dispergierende impfstoffe-zusammensetzung zur oralen verabreichung
DK98950200T DK1024824T3 (da) 1997-10-27 1998-10-27 Dispergerende vaccinesammensætning i fast form til oral indgivelse
AU96359/98A AU9635998A (en) 1997-10-27 1998-10-27 Solid dispersing vaccine composition for oral delivery
JP2000517737A JP2001521007A (ja) 1997-10-27 1998-10-27 経口固体分散ワクチン組成物
DE69826019T DE69826019T2 (de) 1997-10-27 1998-10-27 Feste dispergierende impfstoffe-zusammensetzung zur oralen verabreichung
US10/136,000 US20020197321A1 (en) 1997-10-27 2002-04-29 Solid dispersing vaccine composition for oral delivery
US10/835,680 US20040265377A1 (en) 1997-10-27 2004-04-30 Solid dispersing vaccine composition for oral delivery
US11/778,788 US20080014260A1 (en) 1997-10-27 2007-07-17 Solid dispersing vaccine composition for oral delivery
US12/714,832 US20100330183A1 (en) 1997-10-27 2010-03-01 Solid dispersing vaccine composition for oral delivery
US13/181,128 US20120034305A1 (en) 1997-10-27 2011-07-12 Solid dispersing vaccine composition for oral delivery

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9722682.3A GB9722682D0 (en) 1997-10-27 1997-10-27 Pharmaceutical products

Publications (1)

Publication Number Publication Date
GB9722682D0 true GB9722682D0 (en) 1997-12-24

Family

ID=10821162

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9722682.3A Ceased GB9722682D0 (en) 1997-10-27 1997-10-27 Pharmaceutical products

Country Status (10)

Country Link
EP (1) EP1024824B1 (https=)
JP (1) JP2001521007A (https=)
AT (1) ATE274919T1 (https=)
AU (1) AU9635998A (https=)
DE (1) DE69826019T2 (https=)
DK (1) DK1024824T3 (https=)
ES (1) ES2227885T3 (https=)
GB (1) GB9722682D0 (https=)
PT (1) PT1024824E (https=)
WO (1) WO1999021579A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL148247A0 (en) 1999-08-24 2002-09-12 Teva Pharma A vaccine composition and method of using the same
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
GB0020089D0 (en) * 2000-08-15 2000-10-04 Smithkline Beecham Biolog Vaccine Composition
DE10125731A1 (de) * 2001-05-17 2003-03-06 A I D Autoimmun Diagnostika Gm Darreichungsform von immunologischen Wirkstoffen
WO2004047793A1 (en) 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
EP1599185A1 (en) * 2003-02-28 2005-11-30 Alk-Abello A/S Dosage form having a saccharide matrix
WO2005004923A1 (ja) * 2003-07-10 2005-01-20 Kyowa Hakko Kogyo Co., Ltd. 錠剤およびその製造方法
DE20321887U1 (de) 2003-11-10 2012-01-20 Allergan, Inc. Arzneimittel umfassend niedrige Dosierungen von Desmopressin
EP2322195A2 (en) 2003-11-10 2011-05-18 Reprise Biopharmaceutics, LLC Pharmaceutical compositions including low dosages of desmopressin
US20060210590A1 (en) 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
AU2006299310A1 (en) 2005-10-04 2007-04-12 Alk-Abello A/S Solid vaccine formulation
EP2187926B1 (en) 2007-09-11 2012-01-25 Københavns Universitet Prevention of diabetes by administration of gliadin
EP2163239A1 (de) * 2008-05-27 2010-03-17 Qiagen GmbH Produkte, die Biopartikel enthalten, Verfahren zu ihrer Herstellung
BR112012000951A2 (pt) * 2009-07-17 2016-03-15 Univ Oklahoma State método para imunizar um animal, formulação imunogênica, e, aplicador supralingual
GB201009273D0 (en) * 2010-06-03 2010-07-21 Glaxosmithkline Biolog Sa Novel vaccine
HUE052853T2 (hu) 2010-10-08 2021-05-28 Scherer Technologies Llc R P Orális vakcina gyorsan oldódó dózisforma, keményítõ alkalmazásával
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
TWI745278B (zh) 2014-10-10 2021-11-11 以色列商艾畢克生物實驗有限公司 發泡性降低之疫苗組合物
US11523988B2 (en) * 2018-11-29 2022-12-13 Catalent U.K. Swindon Zydis Limited Oral dispersible vaccine comprising virosomes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
US5298261A (en) * 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
EP0688205A1 (en) * 1993-03-11 1995-12-27 Secretech, Inc. Polymeric mucoadhesives in the delivery of immunogens at mucosal surfaces
US5709861A (en) * 1993-04-22 1998-01-20 Emisphere Technologies, Inc. Compositions for the delivery of antigens
GB9514285D0 (en) * 1995-07-13 1995-09-13 Univ Nottingham Polymeric lamellar substrate particles for drug delivery

Also Published As

Publication number Publication date
PT1024824E (pt) 2004-11-30
AU9635998A (en) 1999-05-17
DK1024824T3 (da) 2004-09-20
WO1999021579A1 (en) 1999-05-06
EP1024824A1 (en) 2000-08-09
DE69826019T2 (de) 2005-09-15
ES2227885T3 (es) 2005-04-01
DE69826019D1 (de) 2004-10-07
ATE274919T1 (de) 2004-09-15
EP1024824B1 (en) 2004-09-01
JP2001521007A (ja) 2001-11-06

Similar Documents

Publication Publication Date Title
GB9722682D0 (en) Pharmaceutical products
IL145982A0 (en) Vaccines
EP1733735A3 (en) Methods and products for inducing mucosal immunity
GB0025577D0 (en) Vaccine
AU3040995A (en) Treatment of autoimmune diseases by oral administration of autoantigens
HUP0200329A3 (en) Pharmaceutical formulations for treatment of mucosal associated conditions with an immune response modifier
AP9801392A0 (en) Concentrated antibody preparation.
LU91328I2 (fr) Vaccin papillomavirus humain Ätypes 6,11,16,18Ü(recombinant, adsorbé)
NO20001768D0 (no) Viruskapsomervaksine, fremgangsmåte til fremstilling samt anvendelse derav
IL154404A0 (en) Oral solid dose vaccine
EP1471936A4 (en) HIV VACCINE AND METHOD OF USE
IL113772A0 (en) Mucosal administration of pneumococcal antigens
MY127452A (en) Vaccines.
MY128929A (en) Vaccine against hepatitis a and hepatitis b
HUP0400495A3 (en) Oral mucosal dosage forms of apomorphine, suitable for the administration via oral mucosal tissue
GB9303681D0 (en) Vaccines
AU2003294192A8 (en) Inclusion bodies as antigens for the oral vaccination of animals
UA23884A (uk) Спосіб підвищення імунітету у сільськогосподарськи х птиць при вакцинації її живими вірус-вакцинами
GC0000171A (en) Novel vaccine formulations, methods for preparing them and their use in therapy
FR2698271B1 (fr) Vaccin contre le virus de la leucémie bovine, nouveau peptide immunogène et kit de vaccination.
HU9403560D0 (en) Process for the preparation of inactivated vaccine against influenza in human ando preparation of aluminium-phosphate gel-free, stabile composition for nasal treatment
WO1999061049A3 (en) Model for infection by a pathogen using administration of nucleic acids
HK1057694A (en) Oral solid dose vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)